Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis : : workshop summary / / Anna Nicholson [and three others], Rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resist...

Full description

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Place / Publishing House:Washington, District of Columbia : : National Academies Press,, [2013]
2013
Year of Publication:2013
Language:English
Online Access:
Physical Description:1 online resource (170 pages) :; illustrations (some color)
Notes:
  • "Forum on drug discovery, development, and translation."--Cover.
  • "Workshop was held on July 31- August 1, 2012 in Washington, D.C.
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Logistics, Supply, and Demand
  • Financing of MDR TB SLDs
  • Innovative Suggestions and Potential Solutions.